HomeInsightsStock Comparison

Q Line Biotech Ltd vs Zr2 Bioenergy Ltd Stock Comparison

Q Line Biotech Ltd vs Zr2 Bioenergy Ltd Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

  • The Latest Trading Price of Q-Line Biotech Ltd is ₹ 529.55 as of 23 Oct 15:30 . The P/E Ratio of Q-Line Biotech Ltd changed from 0 on March 2025 to 0 on March 2026 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of ZR2 Bioenergy Ltd changed from 1120 on March 2025 to 0 on March 2026 . This represents a CAGR of -100.00% over 4 years The Market Cap of Q-Line Biotech Ltd changed from ₹ 0 crore on March 2025 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of ZR2 Bioenergy Ltd changed from ₹ 99.93 crore on March 2025 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 4 years The revenue of Q-Line Biotech Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 110.94 crore. This represent the decline of -100% The revenue of ZR2 Bioenergy Ltd for the Jun '26 is ₹ 0.42 crore as compare to the Mar '26 revenue of ₹ 0.44 crore. This represent the decline of -4.55% The ebitda of Q-Line Biotech Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 33.57 crore. This represent the decline of -100% The ebitda of ZR2 Bioenergy Ltd for the Jun '26 is ₹ 0.25 crore as compare to the Mar '26 ebitda of ₹ 0.23 crore. This represent the growth of 8.7% The net profit of Q-Line Biotech Ltd changed from ₹ 17.38 crore to ₹ 0 crore over 3 quarters. This represents a CAGR of -100.00% The net profit of ZR2 Bioenergy Ltd changed from ₹ -0.26 crore to ₹ 0.22 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Q-Line Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of ZR2 Bioenergy Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Q-Line Biotech Ltd

  • Q-Line Biotech Limited was originally incorporated as 'POCT Services Private Limited' on November 10, 2010 as a Private limited company dated November 10, 2010 issued by the Assistant Registrar of Companies, Uttar Pradesh and Uttarakhand.
  • Subsequently, the name of Company was changed to 'Q-Line Biotech Private Limited on July 23, 2021.
  • Further, Company was converted from a private company to public company and the name of Company was changed to 'Q-Line Biotech Limited', via fresh certificate of incorporation dated March 08, 2025 issued by Central Processing Centre. The Company is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs.

About ZR2 Bioenergy Ltd

  • ZR2 Bioenergy Limited was initially set up as a proprietary concern in 1911, which later on converted into a Private Limited Company as Sardesai Brothers Private Limited in 1939.
  • In 1961, it was converted into a Public Limited Company under the name and style 'Sardesai Brothers Limited' and was again changed to Gujchem Distillers India Limited' in 1974.
  • Subsequent to the takeover by the new Management, the Company has changed its name from Gujchem Distillers India Limited to ZR2 Bioenergy Limited with due approval from Registrar of Companies on March 27, 2025. The Company is engaged in the manufacture and sale of Industrial Alcohol, Acetaldehyde, Acetic Acid, and Auxiliaries and Chemicals in India.
  • It also offers Monochloro Acetic Acid and Carboxy Methyl Cellulose. In 2023, the Company has incorporated wholly-owned subsidiary company called Sera Code Private Limited on July 28, 2022 to carry on the business of Information Technology.

FAQs for the comparison of Q-Line Biotech Ltd and ZR2 Bioenergy Ltd

Which company has a larger market capitalization, Q-Line Biotech Ltd or ZR2 Bioenergy Ltd?

Market cap of Q-Line Biotech Ltd is 1,235 Cr while Market cap of ZR2 Bioenergy Ltd is 186 Cr

What are the key factors driving the stock performance of Q-Line Biotech Ltd and ZR2 Bioenergy Ltd?

The stock performance of Q-Line Biotech Ltd and ZR2 Bioenergy Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Q-Line Biotech Ltd and ZR2 Bioenergy Ltd?

As of October 25, 2026, the Q-Line Biotech Ltd stock price is INR ₹529.55. On the other hand, ZR2 Bioenergy Ltd stock price is INR ₹117.0.

How do dividend payouts of Q-Line Biotech Ltd and ZR2 Bioenergy Ltd compare?

To compare the dividend payouts of Q-Line Biotech Ltd and ZR2 Bioenergy Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions